Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index; none of the 3 sources its claims cite is checked for support yet.

Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program

Open access
Perez, Erick Roman, Knapp, Joshua A., Horn, Carl K., Stillman, Stedra L., Evans, James E., Arfsten, Darryl P. · 2016 · Journal of Analytical Toxicology

Abstract

Liquid chromatography-tandem mass spectrometry (LC-MS-MS) offers specific advantages over gas chromatography-mass spectrometry (GC-MS) such as the ability to identify and measure a broader range of compounds with minimal sample preparation. Comparative analysis of LC-MS-MS versus GC-MS was performed for urinalysis detection of five benzodiazepine compounds currently part of the Department of Defense (DoD) Drug Demand Reduction Program (DDRP) testing panel; alpha-hydroxyalprazolam, oxazepam, lorazepam, nordiazepam and temazepam. In the analyses of internally prepared control urine samples at concentrations around the DDRP administrative decision point for benzodiazepines (100 ng/mL), both technologies produced comparable results with average accuracies between 99.7 and 107.3% and average coefficients of variation (%CV) <9%. Analysis of service member specimens that screened positive for benzodiazepines using both technologies produced comparable results for all analytes. Different degrees of matrix effect were observed for all analytes in the LC-MS-MS analysis. However, the effects were controlled by using deuterated internal standards (ISTDs). Additionally, there was a 39% increase in nordiazepam mean concentration analyzed by LC-MS-MS due to suppression of the ISTD ion by the flurazepam metabolite 2-hydroxyethylflurazepam. The ease and speed of sample extraction, the broader range of compounds that can be analyzed and shorter run time make the LC-MS-MS technology a suitable and expedient alternative confirmation technology for benzodiazepine testing.

Overview

CoChat Summary

TL;DR

LC–MS-MS and GC–MS produced comparable urine benzodiazepine confirmation results for five DDRP panel compounds, with acceptable accuracy and precision around the 100 ng/mL administrative decision point. LC–MS-MS offered easier/faster extraction, shorter run times, and lower LOD/LOQ for some analytes, though a flurazepam metabolite interfered with nordiazepam quantitation.

Key findings

  • At concentrations around the DDRP benzodiazepine decision point (100 ng/mL), both methods showed comparable performance: average accuracies between 99.7 and 107.3% and average %CV <9% in internally prepared control urine samples. At 75, 100, and 125 ng/mL, GC–MS average accuracy was 102% with CVs <5%, while LC–MS-MS average accuracy was 105% with CVs <7%; the % difference between methods ranged from 0.14 to 5.07%.
  • For LORA, NORD, and TEMA, LC–MS-MS attained lower LOD/LOQ values (1.96–2.15 ng/mL; CVs 3.4–8.1%) than GC–MS (6.13–26.30 ng/mL; CVs 0.4–4.8%). AHAL and OXAZ had equivalent LOD/LOQ values for both technologies.
  • LC–MS-MS matrix effects caused target ion enhancement of 2–52% for all analytes except NORD; NORD at 100 ng/mL showed <1% suppression. These effects were controlled with deuterated internal standards, with type C sample accuracies of 98.3–102.5% and CVs <5%.
  • The flurazepam metabolite 2-hydroxyethylflurazepam (2HEF) suppressed the NORD ISTD ion by 36% and increased NORD mean concentration by 39% in LC–MS-MS versus GC–MS. TEMA GC–MS analysis failed in 3 of 5 replicates containing club drug mixture, while LC–MS-MS had no such problem. In service member specimens, no significant difference was found between methods for NORD, OXAZ, LORA, and AHAL; TEMA differed significantly (P = 0.025), but the mean percent difference was <3%.

Methods

  • Urine samples were analyzed for five benzodiazepines: alpha-hydroxyalprazolam (AHAL), oxazepam (OXAZ), lorazepam (LORA), nordiazepam (NORD), and temazepam (TEMA). Internally prepared controls and sample material were fortified at concentrations including 20, 40, 75, 100, 125, 200, 500, and 1,000 ng/mL; GC–MS used 10 sets and LC–MS-MS used 9 sets of four replicates per target concentration.
  • GC–MS used enzymatic hydrolysis, solid-phase extraction, derivatization with MTBSTFA, and selected ion monitoring on Agilent 7890 GC/5975 MS instruments. LC–MS-MS used enzymatic hydrolysis, solid-phase extraction without derivatization, and multiple reaction monitoring on a Waters ACQUITY LC coupled to a Quattro Micro triple quadrupole mass spectrometer.
  • Method comparison included LOD/LOQ/ULOL determination, matrix effect assessment by the Matuszewski method, interference testing with 40 ng/mL target analytes plus 5,000 ng/mL interferants, and side-by-side analysis of anonymized service member urine specimens that screened positive for benzodiazepines by immunoassay (Nov 2012–Jul 2013). Statistical analyses used Excel 2010 and Minitab 17, including regression ANOVA and Student’s t-tests.

Limitations

  • The paper does not include a formal limitations section.
  • Evident from the text: the NORD interference by 2HEF occurred at 5,000 ng/mL, which the authors note was 125 times greater than the sample concentration and higher than literature suggests would be physiologically realistic; the authors still recommend considering this effect during method development if the same parent and transition ions are chosen.
  • Evident from the text: TEMA GC–MS analysis failed in 3 of 5 club-drug-mixture replicates, and TEMA results differed significantly between technologies (P = 0.025), although the mean percent difference was <3%. Some service member specimen comparisons had small sample sizes (LORA n = 7; AHAL n = 8).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/jat/bkv140

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 2 Not checked · 40 Own results and interpretations

26 more claims

Create a free account to see all 42 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 7 references

Cited by

See all 106

Metadata

Authors
Perez, E. R., Knapp, J. A., Horn, C. K., Stillman, S. L., Evans, J. E., & Arfsten, D. P.
Affiliations
United States Department of the Navy (US)
Corresponding author
Arfsten, Darryl P.
Venue
Journal of Analytical Toxicology
Published
2016-01-10
Volume
40
Issue
3
Pages
201-207
ISSN
  • 0146-4760 (ISSN-L)
  • 1945-2403
OpenAlex
W2299389374
Cited by
106
References
7
Citations by year
2026: 8 · 2025: 15 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 20 · 2020: 15 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 1
FWCI
5.44
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Journal of Analytical Toxicology (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Pesticide Residue Analysis and Safety
Keywords
benzodiazepines, LC-MS/MS, gas chromatography-mass spectrometry, urine analysis, oxazepam, lorazepam, nordiazepam, temazepam, matrix effects, deuterated internal standards, confirmatory drug testing
MeSH terms
Benzodiazepines, Chromatography, Liquid, Humans, Gas Chromatography-Mass Spectrometry, Tandem Mass Spectrometry, Limit of Detection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program. https://app.cochat.ai/papers/10.1093/jat/bkv140
The paper
Perez, E. R., Knapp, J. A., Horn, C. K., Stillman, S. L., Evans, J. E., & Arfsten, D. P. (2016). Comparison of LC-MS-MS and GC-MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkv140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.